{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T16:11:51Z","timestamp":1792512711807,"version":"4.5.0"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T00:00:00Z","timestamp":1740960000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T00:00:00Z","timestamp":1740960000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Natural Products (NPs) are increasingly utilized worldwide for their potential therapeutic benefits, including central nervous system (CNS) disorders. Studies have shown a\u00e7ai berries mitigating Parkinson\u2019s disease progression through dopaminergic neuroprotection via Nrf-2 HO-1 pathways. Ashwagandha, an evergreen shrub, has shown potential as a therapeutic for neurodegenerative disorders via axonal regeneration in A\u03b225-35-treated cortical neurons in vitro. In most cases, promising NPs are tested using in vitro assays or simpler systems during the early stages of drug discovery. However, a critical challenge lies in the lack of data on blood-brain barrier (BBB) penetration, which is a significant determinant for the successful development of CNS drugs. Our first goal was to test our in-house NP constituent library via the Parallel Artificial Membrane Permeability Assay (PAMPA-BBB), with the aim of understanding their BBB-penetration potential. Of the constituents tested, 255 were found to have moderate to high BBB permeability. Our next goal was to understand if these compounds could exhibit CNS toxicity. Neuronal viability and neurite outgrowth assays were performed with this subset to identify compounds with neurotoxicity potential. Around 35% of compounds tested showed neurite outgrowth inhibition. The habitual and widespread consumption of NPs underscores the importance of subjecting this subset of compounds to additional testing and validation in vivo to ascertain their potential detrimental effects. Understanding BBB permeability and assessing neurotoxicity mechanisms of NPs will significantly benefit the CNS drug discovery community.<\/jats:p>","DOI":"10.1038\/s41598-025-90888-2","type":"journal-article","created":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T03:43:07Z","timestamp":1740973387000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Investigating blood\u2013brain barrier penetration and neurotoxicity of natural products for central nervous system drug development"],"prefix":"10.1038","volume":"15","author":[{"given":"Rintaro","family":"Kato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nivedita","family":"Kinatukara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruili","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhinav","family":"Asthana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menghang","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pranav","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,3]]},"reference":[{"key":"90888_CR1","doi-asserted-by":"publisher","first-page":"112762","DOI":"10.1016\/j.fct.2021.112762","volume":"159","author":"N Basaran","year":"2022","unstructured":"Basaran, N., Pasli, D. & Basaran, A. A. Unpredictable adverse effects of herbal products. Food Chem. Toxicol. 159, 112762. https:\/\/doi.org\/10.1016\/j.fct.2021.112762 (2022).","journal-title":"Food Chem. Toxicol."},{"key":"90888_CR2","doi-asserted-by":"publisher","first-page":"612","DOI":"10.3892\/br.2017.909","volume":"6","author":"S Mathur","year":"2017","unstructured":"Mathur, S. & Hoskins, C. Drug development: Lessons from nature. Biomed. Rep. 6, 612\u2013614. https:\/\/doi.org\/10.3892\/br.2017.909 (2017).","journal-title":"Biomed. Rep."},{"key":"90888_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.toxlet.2024.01.008","volume":"393","author":"VF Abegg","year":"2024","unstructured":"Abegg, V. F. et al. Mechanisms of hepatocellular toxicity associated with the components of St. John\u2019s wort extract hypericin and Hyperforin in HepG2 and HepaRG cells. Toxicol. Lett. 393, 1\u201313. https:\/\/doi.org\/10.1016\/j.toxlet.2024.01.008 (2024).","journal-title":"Toxicol. Lett."},{"key":"90888_CR4","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.jad.2024.03.017","volume":"354","author":"A Song","year":"2024","unstructured":"Song, A. et al. Antidepressant-like effects of Hyperoside on chronic stress-induced depressive-like behaviors in mice: Gut microbiota and short-chain fatty acids. J. Affect. Disord. 354, 356\u2013367. https:\/\/doi.org\/10.1016\/j.jad.2024.03.017 (2024).","journal-title":"J. Affect. Disord"},{"key":"90888_CR5","doi-asserted-by":"publisher","DOI":"10.1002\/ptr.8204","author":"B Farasati Far","year":"2024","unstructured":"Farasati Far, B. et al. The potential role of Hypericum perforatum in wound healing: A literature review on the phytochemicals, pharmacological approaches, and mechanistic perspectives. Phytother Res. https:\/\/doi.org\/10.1002\/ptr.8204 (2024).","journal-title":"Phytother Res."},{"key":"90888_CR6","doi-asserted-by":"publisher","first-page":"5639","DOI":"10.1002\/ptr.8011","volume":"37","author":"Z Peng","year":"2023","unstructured":"Peng, Z. et al. Hypericin as a promising natural bioactive naphthodianthrone: A review of its pharmacology, pharmacokinetics, toxicity, and safety. Phytother Res. 37, 5639\u20135656. https:\/\/doi.org\/10.1002\/ptr.8011 (2023).","journal-title":"Phytother Res."},{"key":"90888_CR7","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.fct.2018.11.041","volume":"123","author":"D Tewari","year":"2019","unstructured":"Tewari, D., Rawat, P. & Singh, P. K. Adverse drug reactions of anticancer drugs derived from natural sources. Food Chem. Toxicol. 123, 522\u2013535. https:\/\/doi.org\/10.1016\/j.fct.2018.11.041 (2019).","journal-title":"Food Chem. Toxicol."},{"key":"90888_CR8","doi-asserted-by":"publisher","first-page":"926507","DOI":"10.3389\/fphar.2022.926507","volume":"13","author":"Z Wang","year":"2022","unstructured":"Wang, Z., Wang, N., Yang, L. & Song, X. Q. Bioactive natural products in COVID-19 therapy. Front. Pharmacol. 13, 926507. https:\/\/doi.org\/10.3389\/fphar.2022.926507 (2022).","journal-title":"Front. Pharmacol."},{"key":"90888_CR9","doi-asserted-by":"publisher","first-page":"10345","DOI":"10.1021\/acs.jmedchem.7b01922","volume":"61","author":"SS Bharate","year":"2018","unstructured":"Bharate, S. S., Mignani, S. & Vishwakarma, R. A. Why are the majority of active compounds in the CNS domain natural products?? A critical analysis. J. Med. Chem. 61, 10345\u201310374. https:\/\/doi.org\/10.1021\/acs.jmedchem.7b01922 (2018).","journal-title":"J. Med. Chem."},{"key":"90888_CR10","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.bbi.2024.10.026","volume":"123","author":"YH Wang","year":"2024","unstructured":"Wang, Y. H. et al. Prophylactic use of probiotics as an adjunctive treatment for ischemic stroke via the gut-spleen-brain axis. Brain Behav. Immun. 123, 784\u2013798 (2024).","journal-title":"Brain Behav. Immun."},{"key":"90888_CR11","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12986-024-00800-4","volume":"21","author":"R Goyal","year":"2024","unstructured":"Goyal, R. et al. Natural products in the management of neurodegenerative diseases. Nutr. Metab. (Lond.). 21, 26. https:\/\/doi.org\/10.1186\/s12986-024-00800-4 (2024).","journal-title":"Nutr. Metab. (Lond)"},{"key":"90888_CR12","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1080\/17460441.2023.2294118","volume":"19","author":"M Dichiara","year":"2024","unstructured":"Dichiara, M. et al. Designing drugs optimized for both blood-brain barrier permeation and intra-cerebral partition. Expert Opin. Drug Discov. 19, 317\u2013329. https:\/\/doi.org\/10.1080\/17460441.2023.2294118 (2024).","journal-title":"Expert Opin. Drug Discov"},{"key":"90888_CR13","doi-asserted-by":"publisher","first-page":"1291246","DOI":"10.3389\/fphar.2023.1291246","volume":"14","author":"R Kato","year":"2023","unstructured":"Kato, R. et al. Development and validation of PAMPA-BBB QSAR model to predict brain penetration potential of novel drug candidates. Front. Pharmacol. 14, 1291246. https:\/\/doi.org\/10.3389\/fphar.2023.1291246 (2023).","journal-title":"Front. Pharmacol."},{"key":"90888_CR14","doi-asserted-by":"publisher","first-page":"e26893","DOI":"10.7759\/cureus.26893","volume":"14","author":"G Hassen","year":"2022","unstructured":"Hassen, G. et al. Clinical implications of herbal supplements in conventional medical practice: A US perspective. Cureus 14, e26893. https:\/\/doi.org\/10.7759\/cureus.26893 (2022).","journal-title":"Cureus"},{"key":"90888_CR15","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1021\/acsptsci.2c00194","volume":"6","author":"A Yasgar","year":"2023","unstructured":"Yasgar, A. et al. Quantitative bioactivity signatures of dietary supplements and natural products. ACS Pharmacol. Transl Sci. 6, 683\u2013701. https:\/\/doi.org\/10.1021\/acsptsci.2c00194 (2023).","journal-title":"ACS Pharmacol. Transl Sci."},{"key":"90888_CR16","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1056\/NEJMsa1504267","volume":"373","author":"AI Geller","year":"2015","unstructured":"Geller, A. I. et al. Emergency department visits for adverse events related to dietary supplements. N. Engl. J. Med. 373, 1531\u20131540. https:\/\/doi.org\/10.1056\/NEJMsa1504267 (2015).","journal-title":"N Engl. J. Med."},{"key":"90888_CR17","doi-asserted-by":"publisher","first-page":"7","DOI":"10.7861\/clinmedicine.13-1-7","volume":"13","author":"P Posadzki","year":"2013","unstructured":"Posadzki, P., Watson, L. K. & Ernst, E. Adverse effects of herbal medicines: An overview of systematic reviews. Clin. Med. (Lond.). 13, 7\u201312. https:\/\/doi.org\/10.7861\/clinmedicine.13-1-7 (2013).","journal-title":"Clin. Med. (Lond)"},{"key":"90888_CR18","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1177\/1715163518779409","volume":"151","author":"AR Barry","year":"2018","unstructured":"Barry, A. R. Patients\u2019 perceptions and use of natural health products. Can. Pharm. J. (Ott). 151, 254\u2013262. https:\/\/doi.org\/10.1177\/1715163518779409 (2018).","journal-title":"Can. Pharm. J. (Ott)"},{"key":"90888_CR19","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/480S82a","volume":"480","author":"FTCM Cheung","year":"2011","unstructured":"Cheung, F. T. C. M. Made in China. Nature 480, 82\u201383. https:\/\/doi.org\/10.1038\/480S82a (2011).","journal-title":"Nature"},{"key":"90888_CR20","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1503\/cmaj.1031558","volume":"170","author":"DG Bailey","year":"2004","unstructured":"Bailey, D. G. & Dresser, G. K. Natural products and adverse drug interactions. CMAJ 170, 1531\u20131532. https:\/\/doi.org\/10.1503\/cmaj.1031558 (2004).","journal-title":"CMAJ"},{"key":"90888_CR21","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.neuro.2021.01.003","volume":"83","author":"S Li","year":"2021","unstructured":"Li, S. et al. Evaluation of chemical compounds that inhibit neurite outgrowth using GFP-labeled iPSC-derived human neurons. Neurotoxicology 83, 137\u2013145. https:\/\/doi.org\/10.1016\/j.neuro.2021.01.003 (2021).","journal-title":"Neurotoxicology"},{"key":"90888_CR22","doi-asserted-by":"publisher","first-page":"5","DOI":"10.5599\/admet.1.1.2","volume":"3","author":"Z Mandic","year":"2013","unstructured":"Mandic, Z. Absorption and drug development. Solubility, permeability and charge State, 2nd edition. Admet Dmpk 1. 3, 5. https:\/\/doi.org\/10.5599\/admet.1.1.2 (2013).","journal-title":"Admet Dmpk 1"},{"key":"90888_CR23","doi-asserted-by":"publisher","first-page":"e542","DOI":"10.1002\/cpz1.542","volume":"2","author":"L Zhang","year":"2022","unstructured":"Zhang, L., Li, S. & Xia, M. High-Throughput neurite outgrowth assay using GFP-Labeled iPSC-Derived neurons. Curr. Protoc. 2, e542. https:\/\/doi.org\/10.1002\/cpz1.542 (2022).","journal-title":"Curr. Protoc."},{"key":"90888_CR24","unstructured":"Wang, Y. & Huang, R. in High-Throughput Screening Assays in Toxicology Vol. 1473 Methods in Molecular Biology (eds Hao Zhu & Menghang Xia) Ch. 13Humana Press, (2016)."},{"key":"90888_CR25","doi-asserted-by":"publisher","unstructured":"Shah, P., Siramshetty, V. B., Mathe, E. & Xu, X. Developing robust human liver microsomal stability prediction models: Leveraging Inter-Species correlation with rat data. Pharmaceutics 16 https:\/\/doi.org\/10.3390\/pharmaceutics16101257 (2024).","DOI":"10.3390\/pharmaceutics16101257"},{"key":"90888_CR26","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1111\/ejn.13585","volume":"46","author":"H Li","year":"2017","unstructured":"Li, H. & Wu, W. Microtubule stabilization promoted axonal regeneration and functional recovery after spinal root avulsion. Eur. J. Neurosci. 46, 1650\u20131662. https:\/\/doi.org\/10.1111\/ejn.13585 (2017).","journal-title":"Eur. J. Neurosci."},{"key":"90888_CR27","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s12032-023-02197-1","volume":"40","author":"MK Roshan","year":"2023","unstructured":"Roshan, M. K., Afshari, A. R., Mirzavi, F., Mousavi, S. H. & Soukhtanloo, M. Combretastatin A-4 suppresses the invasive and metastatic behavior of glioma cells and induces apoptosis in them: In-vitro study. Med. Oncol. 40, 331. https:\/\/doi.org\/10.1007\/s12032-023-02197-1 (2023).","journal-title":"Med. Oncol."},{"key":"90888_CR28","doi-asserted-by":"publisher","first-page":"775602","DOI":"10.3389\/fphar.2021.775602","volume":"12","author":"K He","year":"2021","unstructured":"He, K. et al. Cinobufagin is a selective Anti-Cancer agent against tumors with EGFR amplification and PTEN deletion. Front. Pharmacol. 12, 775602. https:\/\/doi.org\/10.3389\/fphar.2021.775602 (2021).","journal-title":"Front. Pharmacol."},{"key":"90888_CR29","first-page":"297","volume":"2","author":"L Helson","year":"1993","unstructured":"Helson, L. Cephalomannine and 10-deacetyltaxol cytotoxicity in human glial and neuroblastoma cell-lines. Int. J. Oncol. 2, 297\u2013299 (1993).","journal-title":"Int. J. Oncol."},{"key":"90888_CR30","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1111\/bph.12201","volume":"169","author":"AA Fatokun","year":"2013","unstructured":"Fatokun, A. A., Liu, J. O., Dawson, V. L. & Dawson, T. M. Identification through high-throughput screening of 4\u2019-methoxyflavone and 3\u2019,4\u2019-dimethoxyflavone as novel neuroprotective inhibitors of parthanatos. Br. J. Pharmacol. 169, 1263\u20131278. https:\/\/doi.org\/10.1111\/bph.12201 (2013).","journal-title":"Br. J. Pharmacol."},{"key":"90888_CR31","doi-asserted-by":"publisher","unstructured":"Su, Y. et al. Inhibition of the TLR\/NF-kappaB signaling pathway and improvement of autophagy mediates neuroprotective effects of plumbagin in Parkinson\u2019s disease. Oxid. Med. Cell. Longev. 2022 (1837278). https:\/\/doi.org\/10.1155\/2022\/1837278 (2022).","DOI":"10.1155\/2022\/1837278"},{"key":"90888_CR32","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1007\/s11064-019-02837-x","volume":"44","author":"MA Altinoz","year":"2019","unstructured":"Altinoz, M. A. et al. Noscapine, a non-addictive opioid and microtubule-inhibitor in potential treatment of glioblastoma. Neurochem Res. 44, 1796\u20131806. https:\/\/doi.org\/10.1007\/s11064-019-02837-x (2019).","journal-title":"Neurochem Res."},{"key":"90888_CR33","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13195-020-00746-8","volume":"13","author":"Q Su","year":"2021","unstructured":"Su, Q. et al. Trichostatin A ameliorates Alzheimer\u2019s disease-related pathology and cognitive deficits by increasing albumin expression and Abeta clearance in APP\/PS1 mice. Alzheimers Res. Ther. 13, 7. https:\/\/doi.org\/10.1186\/s13195-020-00746-8 (2021).","journal-title":"Alzheimers Res. Ther."},{"key":"90888_CR34","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s11011-019-00501-5","volume":"35","author":"G Smilin Bell Aseervatham","year":"2020","unstructured":"Smilin Bell Aseervatham, G., Abbirami, E., Sivasudha, T. & Ruckmani, K. Passiflora caerulea L. fruit extract and its metabolites ameliorate epileptic seizure, cognitive deficit and oxidative stress in pilocarpine-induced epileptic mice. Metab. Brain Dis. 35, 159\u2013173. https:\/\/doi.org\/10.1007\/s11011-019-00501-5 (2020).","journal-title":"Metab. Brain Dis."},{"key":"90888_CR35","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.toxlet.2021.06.006","volume":"349","author":"K Takashima","year":"2021","unstructured":"Takashima, K. et al. Disruption of postnatal neurogenesis and adult-stage suppression of synaptic plasticity in the hippocampal dentate gyrus after developmental exposure to sterigmatocystin in rats. Toxicol. Lett. 349, 69\u201383. https:\/\/doi.org\/10.1016\/j.toxlet.2021.06.006 (2021).","journal-title":"Toxicol. Lett."},{"key":"90888_CR36","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1002\/ijc.11511","volume":"107","author":"M Stiborova","year":"2003","unstructured":"Stiborova, M. et al. DNA adduct formation by the anticancer drug ellipticine in rats determined by 32P postlabeling. Int. J. Cancer. 107, 885\u2013890. https:\/\/doi.org\/10.1002\/ijc.11511 (2003).","journal-title":"Int. J. Cancer"},{"key":"90888_CR37","first-page":"220","volume":"32","author":"XR Hong","year":"1994","unstructured":"Hong, X. R., Li, M. & Cao, J. Z. Clinical and experimental studies of the dynamic changes in neuropeptides after trauma. Zhonghua Wai Ke Za Zhi. 32, 220\u2013223 (1994).","journal-title":"Zhonghua Wai Ke Za Zhi"},{"key":"90888_CR38","doi-asserted-by":"publisher","first-page":"120358","DOI":"10.1016\/j.lfs.2022.120358","volume":"293","author":"M Zhu","year":"2022","unstructured":"Zhu, M. et al. Chelerythrine inhibits the progression of glioblastoma by suppressing the TGFB1-ERK1\/2\/Smad2\/3-Snail\/ZEB1 signaling pathway. Life Sci. 293, 120358. https:\/\/doi.org\/10.1016\/j.lfs.2022.120358 (2022).","journal-title":"Life Sci."},{"key":"90888_CR39","doi-asserted-by":"publisher","unstructured":"Fang, X. et al. Inhibiting DNA-PK induces glioma stem cell differentiation and sensitizes glioblastoma to radiation in mice. Sci. Transl. Med. 13 https:\/\/doi.org\/10.1126\/scitranslmed.abc7275 (2021).","DOI":"10.1126\/scitranslmed.abc7275"},{"key":"90888_CR40","doi-asserted-by":"publisher","first-page":"111253","DOI":"10.1016\/j.biopha.2021.111253","volume":"137","author":"MS Tahir","year":"2021","unstructured":"Tahir, M. S. et al. Mechanistic new insights of flavonols on neurodegenerative diseases. Biomed. Pharmacother. 137, 111253. https:\/\/doi.org\/10.1016\/j.biopha.2021.111253 (2021).","journal-title":"Biomed. Pharmacother"},{"key":"90888_CR41","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-024-06622-9","author":"NAK Singh","year":"2024","unstructured":"Singh, N. A. K. & Prasad, S. Ellagic acid reverses alterations in the expression of AMPA receptor and its scaffolding proteins in the cerebral cortex and memory decline in STZ-sporadic Alzheimer\u2019 s disease mouse model. Psychopharmacol. (Berl). https:\/\/doi.org\/10.1007\/s00213-024-06622-9 (2024).","journal-title":"Psychopharmacol. (Berl)"},{"key":"90888_CR42","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.brainres.2014.11.056","volume":"1597","author":"H Abu Ghazaleh","year":"2015","unstructured":"Abu Ghazaleh, H., Lalies, M. D., Nutt, D. J. & Hudson, A. L. The modulatory action of Harmane on serotonergic neurotransmission in rat brain. Brain Res. 1597, 57\u201364. https:\/\/doi.org\/10.1016\/j.brainres.2014.11.056 (2015).","journal-title":"Brain Res."},{"key":"90888_CR43","doi-asserted-by":"publisher","first-page":"109600","DOI":"10.1016\/j.cbpc.2023.109600","volume":"268","author":"B Haridevamuthu","year":"2023","unstructured":"Haridevamuthu, B. et al. Trihydroxy Piperlongumine protects aluminium induced neurotoxicity in zebrafish: Behavioral and biochemical approach. Comp. Biochem. Physiol. C Toxicol. Pharmacol. 268, 109600. https:\/\/doi.org\/10.1016\/j.cbpc.2023.109600 (2023).","journal-title":"Comp. Biochem. Physiol. C Toxicol. Pharmacol."},{"key":"90888_CR44","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1111\/cns.14102","volume":"29","author":"B Luo","year":"2023","unstructured":"Luo, B. et al. Apicidin attenuates memory deficits by reducing the Abeta load in APP\/PS1 mice. CNS Neurosci. Ther. 29, 1300\u20131311. https:\/\/doi.org\/10.1111\/cns.14102 (2023).","journal-title":"CNS Neurosci. Ther."},{"key":"90888_CR45","doi-asserted-by":"publisher","first-page":"16816","DOI":"10.18632\/aging.203221","volume":"13","author":"H Xu","year":"2021","unstructured":"Xu, H. et al. Celastrol protects against early brain injury after subarachnoid hemorrhage in rats through alleviating blood-brain barrier disruption and blocking necroptosis. Aging (Albany NY). 13, 16816\u201316833. https:\/\/doi.org\/10.18632\/aging.203221 (2021).","journal-title":"Aging (Albany NY)"},{"key":"90888_CR46","doi-asserted-by":"publisher","first-page":"4165","DOI":"10.1002\/cncr.29636","volume":"121","author":"L Nayak","year":"2015","unstructured":"Nayak, L. et al. Multicenter phase 2 study of patupilone for recurrent or progressive brain metastases from non-small cell lung cancer. Cancer 121, 4165\u20134172. https:\/\/doi.org\/10.1002\/cncr.29636 (2015).","journal-title":"Cancer"},{"key":"90888_CR47","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1039\/b306797c","volume":"20","author":"A Cirla","year":"2003","unstructured":"Cirla, A. & Mann, J. Combretastatins: From natural products to drug discovery. Nat. Prod. Rep. 20, 558\u2013564. https:\/\/doi.org\/10.1039\/b306797c (2003).","journal-title":"Nat. Prod. Rep."},{"key":"90888_CR48","doi-asserted-by":"publisher","unstructured":"Wang, S. et al. Impact of blood-brain barrier to delivering a vascular-disrupting agent: Predictive role of multiparametric MRI in rodent craniofacial metastasis models. Cancers (Basel). 14. https:\/\/doi.org\/10.3390\/cancers14235826 (2022).","DOI":"10.3390\/cancers14235826"},{"key":"90888_CR49","doi-asserted-by":"publisher","first-page":"109938","DOI":"10.1016\/j.cbi.2022.109938","volume":"360","author":"A Yang","year":"2022","unstructured":"Yang, A. et al. Cinobufagin restrains the growth and triggers DNA damage of human hepatocellular carcinoma cells via proteasome-dependent degradation of thymidylate synthase. Chem. Biol. Interact. 360, 109938. https:\/\/doi.org\/10.1016\/j.cbi.2022.109938 (2022).","journal-title":"Chem. Biol. Interact."},{"key":"90888_CR50","doi-asserted-by":"publisher","first-page":"e22862","DOI":"10.1002\/jbt.22862","volume":"35","author":"SS Hsu","year":"2021","unstructured":"Hsu, S. S., Lin, Y. S. & Liang, W. Z. Investigation of cytotoxic effect of the Bufanolide steroid compound Cinobufagin and its related underlying mechanism in brain cell models. J. Biochem. Mol. Toxicol. 35, e22862. https:\/\/doi.org\/10.1002\/jbt.22862 (2021).","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"90888_CR51","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1021\/mp800138w","volume":"6","author":"C Hansch","year":"2009","unstructured":"Hansch, C. & Verma, R. P. Overcoming tumor drug resistance with C2-modified 10-deacetyl-7-propionyl cephalomannines: A QSAR study. Mol. Pharm. 6, 849\u2013860. https:\/\/doi.org\/10.1021\/mp800138w (2009).","journal-title":"Mol. Pharm."},{"key":"90888_CR52","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1186\/s12870-024-05070-z","volume":"24","author":"L Pan","year":"2024","unstructured":"Pan, L. et al. Metabolomics analysis of different diameter classes of Taxus chinensis reveals that the resource allocation is related to carbon and nitrogen metabolism. BMC Plant. Biol. 24, 383. https:\/\/doi.org\/10.1186\/s12870-024-05070-z (2024).","journal-title":"BMC Plant. Biol."},{"key":"90888_CR53","doi-asserted-by":"publisher","unstructured":"D\u2019Aiello, A., Miao, E. & Cheng, H. Advances in the management of central nervous system metastases in Non-Small cell lung Cancer. Cancers (Basel). 15 https:\/\/doi.org\/10.3390\/cancers15030844 (2023).","DOI":"10.3390\/cancers15030844"},{"key":"90888_CR54","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/scrt208","volume":"4","author":"K Kaur","year":"2013","unstructured":"Kaur, K., Mirlashari, M. R., Kvalheim, G. & Kjeldsen-Kragh, J. 3\u2019,4\u2019-Dimethoxyflavone and valproic acid promotes the proliferation of human hematopoietic stem cells. Stem Cell. Res. Ther. 4, 60. https:\/\/doi.org\/10.1186\/scrt208 (2013).","journal-title":"Stem Cell. Res. Ther."},{"key":"90888_CR55","doi-asserted-by":"publisher","unstructured":"Petrocelli, G. et al. Plumbagin, a natural compound with several biological effects and Anti-Inflammatory properties. Life (Basel). 13 https:\/\/doi.org\/10.3390\/life13061303 (2023).","DOI":"10.3390\/life13061303"},{"key":"90888_CR56","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/j.sjbs.2017.03.006","volume":"25","author":"XJ Chen","year":"2018","unstructured":"Chen, X. J., Zhang, J. G. & Wu, L. Plumbagin inhibits neuronal apoptosis, intimal hyperplasia and also suppresses TNF-alpha\/NF-kappaB pathway induced inflammation and matrix metalloproteinase-2\/9 expression in rat cerebral ischemia. Saudi J. Biol. Sci. 25, 1033\u20131039. https:\/\/doi.org\/10.1016\/j.sjbs.2017.03.006 (2018).","journal-title":"Saudi J. Biol. Sci."},{"key":"90888_CR57","doi-asserted-by":"publisher","first-page":"8495","DOI":"10.1021\/acs.jmedchem.0c00855","volume":"63","author":"MA Oliva","year":"2020","unstructured":"Oliva, M. A. et al. Structural basis of Noscapine activation for tubulin binding. J. Med. Chem. 63, 8495\u20138501. https:\/\/doi.org\/10.1021\/acs.jmedchem.0c00855 (2020).","journal-title":"J. Med. Chem."},{"key":"90888_CR58","doi-asserted-by":"publisher","first-page":"5187","DOI":"10.1158\/1078-0432.CCR-04-0360","volume":"10","author":"JW Landen","year":"2004","unstructured":"Landen, J. W. et al. Noscapine crosses the blood-brain barrier and inhibits glioblastoma growth. Clin. Cancer Res. 10, 5187\u20135201. https:\/\/doi.org\/10.1158\/1078-0432.CCR-04-0360 (2004).","journal-title":"Clin. Cancer Res."},{"key":"90888_CR59","doi-asserted-by":"publisher","unstructured":"Jayaraj, R. L. et al. Noscapine prevents rotenone-induced neurotoxicity: Involvement of oxidative stress, neuroinflammation and autophagy pathways. Molecules 26 https:\/\/doi.org\/10.3390\/molecules26154627 (2021).","DOI":"10.3390\/molecules26154627"},{"key":"90888_CR60","doi-asserted-by":"publisher","unstructured":"Bouyahya, A. et al. Pharmacological properties of trichostatin A, focusing on the anticancer potential: A comprehensive review. Pharmaceuticals (Basel). 15 https:\/\/doi.org\/10.3390\/ph15101235 (2022).","DOI":"10.3390\/ph15101235"},{"key":"90888_CR61","doi-asserted-by":"publisher","first-page":"2280","DOI":"10.3389\/fmicb.2019.02280","volume":"10","author":"Y Zhang","year":"2019","unstructured":"Zhang, Y. et al. Trichostatin A, a Histone deacetylase inhibitor, alleviates eosinophilic meningitis induced by angiostrongylus cantonensis infection in mice. Front. Microbiol. 10, 2280. https:\/\/doi.org\/10.3389\/fmicb.2019.02280 (2019).","journal-title":"Front. Microbiol."},{"key":"90888_CR62","doi-asserted-by":"publisher","unstructured":"Aboulaghras, S. et al. Health benefits and pharmacological aspects of chrysoeriol. Pharmaceuticals (Basel). 15 https:\/\/doi.org\/10.3390\/ph15080973 (2022).","DOI":"10.3390\/ph15080973"},{"key":"90888_CR63","doi-asserted-by":"publisher","unstructured":"Liang, Z. & Maher, P. Structural requirements for the neuroprotective and anti-inflammatory activities of the flavanone sterubin. Antioxid. (Basel). 11 https:\/\/doi.org\/10.3390\/antiox11112197 (2022).","DOI":"10.3390\/antiox11112197"},{"key":"90888_CR64","doi-asserted-by":"publisher","unstructured":"Wang, C. R. et al. Chrysoeriol improves the early development potential of porcine oocytes by maintaining lipid homeostasis and improving mitochondrial function. Antioxid. (Basel). 13 https:\/\/doi.org\/10.3390\/antiox13010122 (2024).","DOI":"10.3390\/antiox13010122"},{"key":"90888_CR65","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.brainres.2016.04.076","volume":"1646","author":"Y You","year":"2016","unstructured":"You, Y. et al. Protective effects of PGC-1alpha via the mitochondrial pathway in rat brains after intracerebral hemorrhage. Brain Res. 1646, 34\u201343. https:\/\/doi.org\/10.1016\/j.brainres.2016.04.076 (2016).","journal-title":"Brain Res."},{"key":"90888_CR66","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/0022-3913(71)90128-4","volume":"25","author":"DF Duperon","year":"1971","unstructured":"Duperon, D. F., Nevile, M. D. & Kasloff, Z. Clinical evaluation of corrosion resistance of conventional alloy, spherical-particle alloy, and dispersion-phase alloy. J. Prosthet. Dent. 25, 650\u2013656. https:\/\/doi.org\/10.1016\/0022-3913(71)90128-4 (1971).","journal-title":"J. Prosthet. Dent."},{"key":"90888_CR67","doi-asserted-by":"publisher","first-page":"111802","DOI":"10.1016\/j.fct.2020.111802","volume":"146","author":"V Zingales","year":"2020","unstructured":"Zingales, V., Fernandez-Franzon, M., Ruiz, M. J. & Sterigmatocystin occurrence, toxicity and molecular mechanisms of action\u2014A review. Food Chem. Toxicol. 146, 111802. https:\/\/doi.org\/10.1016\/j.fct.2020.111802 (2020).","journal-title":"Food Chem. Toxicol."},{"key":"90888_CR68","doi-asserted-by":"publisher","first-page":"111493","DOI":"10.1016\/j.fct.2020.111493","volume":"142","author":"V Zingales","year":"2020","unstructured":"Zingales, V., Fernandez-Franzon, M. & Ruiz, M. J. The role of mitochondria in sterigmatocystin-induced apoptosis on SH-SY5Y cells. Food Chem. Toxicol. 142, 111493. https:\/\/doi.org\/10.1016\/j.fct.2020.111493 (2020).","journal-title":"Food Chem. Toxicol."},{"key":"90888_CR69","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/nrd2094","volume":"6","author":"MN Pangalos","year":"2007","unstructured":"Pangalos, M. N., Schechter, L. E. & Hurko, O. Drug development for CNS disorders: Strategies for balancing risk and reducing attrition. Nat. Rev. Drug Discov. 6, 521\u2013532. https:\/\/doi.org\/10.1038\/nrd2094 (2007).","journal-title":"Nat. Rev. Drug Discov"},{"key":"90888_CR70","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.therap.2020.12.006","volume":"76","author":"M Charveriat","year":"2021","unstructured":"Charveriat, M., Lafon, V., Mouthon, F. & Zimmer, L. Innovative approaches in CNS drug discovery. Therapie 76, 101\u2013109. https:\/\/doi.org\/10.1016\/j.therap.2020.12.006 (2021).","journal-title":"Therapie"},{"key":"90888_CR71","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1602\/neurorx.2.4.554","volume":"2","author":"MS Alavijeh","year":"2005","unstructured":"Alavijeh, M. S., Chishty, M., Qaiser, M. Z. & Palmer, A. M. Drug metabolism and pharmacokinetics, the blood-brain barrier, and central nervous system drug discovery. NeuroRx 2, 554\u2013571 (2005).","journal-title":"NeuroRx"},{"key":"90888_CR72","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/alzrt225","volume":"5","author":"S Meister","year":"2013","unstructured":"Meister, S. et al. Nanoparticulate flurbiprofen reduces amyloid-beta42 generation in an in vitro blood-brain barrier model. Alzheimers Res. Ther. 5, 51 (2013).","journal-title":"Alzheimers Res. Ther."},{"key":"90888_CR73","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1001\/jama.285.13.1719","volume":"285","author":"RL Sacco","year":"2001","unstructured":"Sacco, R. L. et al. Glycine antagonist in neuroprotection for patients with acute stroke: GAIN Americas: A randomized controlled trial. Jama 285, 1719\u20131728 (2001).","journal-title":"Jama"},{"key":"90888_CR74","doi-asserted-by":"publisher","first-page":"120351","DOI":"10.1016\/j.ijpharm.2021.120351","volume":"599","author":"M Choudhari","year":"2021","unstructured":"Choudhari, M. et al. Evolving new-age strategies to transport therapeutics across the blood-brain-barrier. Int. J. Pharm. 599, 120351 (2021).","journal-title":"Int. J. Pharm."},{"issue":"Suppl 1","key":"90888_CR75","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1186\/1471-2377-9-S1-S3","volume":"9","author":"WA Banks","year":"2009","unstructured":"Banks, W. A. Characteristics of compounds that cross the blood-brain barrier. BMC Neurol. 9 (Suppl 1), S3 (2009).","journal-title":"BMC Neurol."},{"key":"90888_CR76","doi-asserted-by":"publisher","first-page":"11","DOI":"10.4137\/PMC.S13384","volume":"6","author":"JL Mikitsh","year":"2014","unstructured":"Mikitsh, J. L. & Chacko, A. M. Pathways for small molecule delivery to the central nervous system across the blood-brain barrier. Perspect. Med. Chem. 6, 11\u201324 (2014).","journal-title":"Perspect. Medicin Chem."},{"key":"90888_CR77","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3389\/fendo.2020.00025","volume":"11","author":"YP Silva","year":"2020","unstructured":"Silva, Y. P., Bernardi, A. & Frozza, R. L. The role of short-chain fatty acids from gut microbiota in gut-brain communication. Front. Endocrinol. (Lausanne). 11, 25. https:\/\/doi.org\/10.3389\/fendo.2020.00025 (2020).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"90888_CR78","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/s41575-019-0157-3","volume":"16","author":"B Dalile","year":"2019","unstructured":"Dalile, B., Van Oudenhove, L., Vervliet, B. & Verbeke, K. The role of short-chain fatty acids in microbiota-gut-brain communication. Nat. Rev. Gastroenterol. Hepatol. 16, 461\u2013478. https:\/\/doi.org\/10.1038\/s41575-019-0157-3 (2019).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"90888_CR79","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.neuint.2016.06.011","volume":"99","author":"RM Stilling","year":"2016","unstructured":"Stilling, R. M. et al. The neuropharmacology of butyrate: The bread and butter of the microbiota-gut-brain axis? Neurochem. Int. 99, 110\u2013132. https:\/\/doi.org\/10.1016\/j.neuint.2016.06.011 (2016).","journal-title":"Neurochem Int."},{"key":"90888_CR80","doi-asserted-by":"publisher","first-page":"1033479","DOI":"10.3389\/fendo.2022.1033479","volume":"13","author":"H Du","year":"2022","unstructured":"Du, H., Meng, X., Yao, Y. & Xu, J. The mechanism and efficacy of GLP-1 receptor agonists in the treatment of Alzheimer\u2019s disease. Front. Endocrinol. (Lausanne). 13, 1033479. https:\/\/doi.org\/10.3389\/fendo.2022.1033479 (2022).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"90888_CR81","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1146\/annurev-med-042320-014032","volume":"73","author":"EA Mayer","year":"2022","unstructured":"Mayer, E. A., Nance, K. & Chen, S. The gut-brain axis. Annu. Rev. Med. 73, 439\u2013453 (2022).","journal-title":"Annu. Rev. Med."},{"key":"90888_CR82","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1172\/JCI76304","volume":"125","author":"EA Mayer","year":"2015","unstructured":"Mayer, E. A., Tillisch, K. & Gupta, A. Gut\/brain axis and the microbiota. J. Clin. Invest. 125, 926\u2013938 (2015).","journal-title":"J. Clin. Invest."},{"key":"90888_CR83","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1111\/j.1365-2982.2012.01906.x","volume":"24","author":"P Bercik","year":"2012","unstructured":"Bercik, P., Collins, S. M. & Verdu, E. F. Microbes and the gut-brain axis. Neurogastroenterol Motil. 24, 405\u2013413 (2012).","journal-title":"Neurogastroenterol Motil."},{"key":"90888_CR84","doi-asserted-by":"crossref","unstructured":"Sachana, M., Flaskos, J. & Hargreaves, A. J. In In Reproductive and Developmental Toxicology. 227\u2013252 (eds Gupta, R. C.) (Academic, 2011).","DOI":"10.1016\/B978-0-12-382032-7.10019-0"},{"key":"90888_CR85","doi-asserted-by":"publisher","unstructured":"Coy-Barrera, E., Ogungbe, I. V. & Schmidt, T. J. Natural products for drug discovery in the 21st century: Innovations for novel therapeutics. Molecules 28 https:\/\/doi.org\/10.3390\/molecules28093690 (2023).","DOI":"10.3390\/molecules28093690"},{"key":"90888_CR86","doi-asserted-by":"publisher","first-page":"960556","DOI":"10.3389\/fphar.2022.960556","volume":"13","author":"M Heydari","year":"2022","unstructured":"Heydari, M. et al. Clinical safety of natural products, an evidence-based approach. Front. Pharmacol. 13, 960556. https:\/\/doi.org\/10.3389\/fphar.2022.960556 (2022).","journal-title":"Front. Pharmacol."},{"key":"90888_CR87","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.ctim.2006.06.007","volume":"15","author":"N Lynch","year":"2007","unstructured":"Lynch, N. & Berry, D. Differences in perceived risks and benefits of herbal, over-the-counter conventional, and prescribed conventional, medicines, and the implications of this for the safe and effective use of herbal products. Complement. Ther. Med. 15, 84\u201391. https:\/\/doi.org\/10.1016\/j.ctim.2006.06.007 (2007).","journal-title":"Complement. Ther. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-90888-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-90888-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-90888-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T06:57:09Z","timestamp":1741330629000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-90888-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,3]]},"references-count":87,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["90888"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-90888-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,3]]},"assertion":[{"value":"23 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7431"}}